Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Innoviva Inc (INVA)

Innoviva Inc (INVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Innoviva Inc 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 USA

www.inva.com Employees: 112 P: 650-238-9600

Description:

Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.

Key Statistics

Overview:

Market Capitalization, $K 1,251,240
Enterprise Value, $K 1,503,960
Shares Outstanding, K 62,562
Annual Sales, $ 310,460 K
Annual Net Income, $ 179,720 K
Last Quarter Sales, $ 99,900 K
Last Quarter Net Income, $ -34,690 K
EBIT, $ 161,870 K
EBITDA, $ 199,640 K
60-Month Beta 0.57
% of Insider Shareholders 1.70%
% of Institutional Shareholders 99.12%
Float, K 61,498
% Float 98.30%
Short Volume Ratio 0.15

Growth:

1-Year Return 46.09%
3-Year Return 12.61%
5-Year Return 60.77%
5-Year Revenue Growth 18.95%
5-Year Earnings Growth -36.26%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.68 on 07/31/24
Next Earnings Date 11/06/24
Earnings Per Share ttm 2.88
EPS Growth vs. Prev Qtr -97.06%
EPS Growth vs. Prev Year -97.96%
Annual Dividend Yield 0.00%
Most Recent Dividend 0.250 on 09/08/15
Next Ex-Dividends Date 09/08/15
Dividend Payable Date 09/30/15
Dividend Payout Ratio 0.00%

INVA Ratios

Ratio
Price/Earnings ttm 10.38
Price/Earnings forward 38.86
Price/Earnings to Growth N/A
Return-on-Equity % 20.74%
Return-on-Assets % 11.35%
Profit Margin % 57.89%
Debt/Equity 0.67
Price/Sales 4.01
Price/Cash Flow 5.56
Price/Book 1.83
Book Value/Share 10.64
Interest Coverage 11.13

INVA Dividends

Date Value
09/08/15 $0.2500
06/10/15 $0.2500
03/10/15 $0.2500
11/21/14 $0.2500
08/26/14 $0.2500
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar